Navigation Links
Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
Date:8/19/2008

BURLINGAME, Calif., August 19 /PRNewswire-FirstCall/ -- Urigen Pharmaceuticals, Inc. (OTC Bulletin Board: URGP, http://www.urigen.com), a specialty pharmaceutical company focused on the development and commercialization of treatments for urological disorders, today announced the U.S. Patent and Trademark Office has issued the first patent for the use of URG101, an investigational, bladder instillation treatment for Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC). Patent number US 7,414,039 broadly covers the use of the URG101 product in the treatment of PBS/IC. The term of the patent extends into 2025.

"Not only does this patent establish protection for the use of URG101 in Painful Bladder Syndrome and Interstitial Cystitis; it also validates the excellent intellectual property guidance provided by Tom Jurgensen, JD of Catalyst Law and Stephen Reiter, PhD, JD of Foley & Lardner," stated William J. Garner, MD, President and CEO of Urigen. "We will continue to execute our intellectual property strategy to strengthen our proprietary position in the field of PBS/IC."

Urigen has announced positive results from a Phase 2 study of URG101. The study was a multi-center, double-blind, placebo-controlled, crossover trial. Findings from the study included:

-- Primary Endpoint -- Improvement in Average Daytime Pain (p=0.03).

-- Secondary Endpoints -- Improvement in Daytime Urgency (p=0.03) and Total Symptom Score (p=0.03). In addition, patients reported improved symptom relief with URG101 as measured by PORIS (p=0.01).

About URG101

URG101 is a pharmaceutical treatment for Painful Bladder Syndrome/Interstitial Cystitis that is instilled into the bladder. URG101 works with lidocaine reducing the sensations of pain, urge and muscle spasms and heparin, a glycosaminoglycan, coating the bladder wall thus augmenting the natural heparinoids.

About Painful Bladder Syndrome/In
'/>"/>

SOURCE Urigen Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
2. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
3. Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
4. Medco Announces Research Collaboration with FDA Focused on Personalized Medicine
5. AMDL Announces Teleconference to Discuss Its Second Quarter 2008 Financial Results
6. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
7. Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer
8. Pregis Announces Second Quarter 2008 Financial Results
9. WuXi PharmaTech Announces Second Quarter 2008 Results
10. Assurant Announces Two Executive Appointments
11. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... Raleigh, NC (PRWEB) April 18, 2015 ... the risk of developing mesothelioma later in life, but ... ways from mesothelioma that is unrelated to radiation. Surviving ... study on its website. Click here to read ... and Australia compared the cases of 45 patients who ...
(Date:4/18/2015)... April 18, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... South Carolina Physical Therapy Association Annual Conference to ... Center in Greenville, SC. , The SCAPTA ... exhibits with products and services. , Representatives ...
(Date:4/17/2015)... Bradley, Illinois (PRWEB) April 17, 2015 ... host a Party on the Patio from 2 p.m. ... which is located at 1320 Executive Ct. in Pekin, ... on Medicaid, who need some help to maintain their ... steel drums, and tropical treats will be served during ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
(Date:4/17/2015)... April 17, 2015 Representatives Jim Himes ... and Treatment Act HR 1849 in congress on April ... and treatment for patients with the genetic disease. ... past, would be the first to create a federally ... treatment of hereditary hemorrhagic telangiectasia. This would effectively prevent ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... 2010) High doses of antioxidant nutritional supplements, such ... cells, which may predispose supplement-takers to developing cancer, according to ... The study, led by Eduardo Marbn, M.D., Ph.D., director ... the medical journal Stem Cells . The study ...
... find early stage cancers and precancerous growths than current ... -- Noninvasive stool DNA testing can detect two types ... in colon cancer prevention, say two new studies. , ... testing has higher detection rates for curable stage colorectal ...
... readmissions, study finds , TUESDAY, May 4 (HealthDay News) -- ... heart failure patient discharged from the hospital reduces the chance ... but that preventive measure is more often ignored than observed, ... 30,000 hospital patients covered by Medicare found that fewer than ...
... CINCINNATIThe popular diabetes medication metformin works in different fashion ... could lead to wider use of the drugparticularly in ... like tuberous sclerosis and lymphangioleiomyomatosis (LAM). The ... scientific director of UC,s Metabolic Diseases Institute, are published ...
... many times have you, after a particularly hard day, reached ... people, but for those trying to lose weight, it can ... programs never even address it. They focus on choosing ... key question: how can people who have eaten to cope ...
... ... cleaning machine that combines high impact cleaning efficiency with extended operating life, reduced life cycle ... can be completely stripped and rebuilt for maintenance ON-SITE in less than 15 minutes. ... (PRWEB) May 4, 2010 -- ...
Cached Medicine News:Health News:High doses of antioxidant supplements induce stem cell genetic abnormalities 2Health News:New Test for Colon Cancer Under Development 2Health News:Hospitals Falling Short on Heart Patients' Follow-Up Care 2Health News:Popular diabetes drug works differently than thought 2Health News:Managing the emotions behind eating 2Health News:BETE Fog Nozzle Announces HydroWhirl™ Orbitor – Clean-In-Place Rotating Tank Cleaning Machine with High Impact Cleaning for Extended Operating Life 2
(Date:4/17/2015)... April 17, 2015  Over the next five years, the ... grow, with ArcView predicting that 14 more states will legalize ... The U.S. market for legal cannabis grew 74 percent in ... Analysts project the market could grow more than fourfold to ... soften their stance on marijuana. Cannabiz Mobile Inc. ...
(Date:4/17/2015)... April 17, 2015 Today, the Pharmaceutical ... employees from 12 biopharmaceutical companies as "We Work ... policy advocacy and community service. Established ... Awards were created by the biopharmaceutical industry to ... their careers, but have also shown an outstanding ...
(Date:4/17/2015)... , April 17, 2015   IBA ... of radiopharmaceuticals, announced today that it has signed a ... North America, Inc. (IBAM NA), to Illinois Health and Science ... operate as an independent company headquartered in ... to take advantage of new product and footprint synergies. ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Md., Sept. 11 Northwest,Biotherapeutics, Inc. (OTC Bulletin ... "Company") today announced the most recent long-term,follow-up data, ... I and Phase,I/II clinical trials with DCVax(R)-Brain, which ... multiforme, the most lethal type of brain,cancer. This ...
... AUSTIN, Texas, Sept. 10 The first-ever human,clinical ... tea was,recently conducted, testing whether the tea can ... new trial also generated the first human safety ... that,short-term consumption of rooibos tea is safe for ...
Cached Medicine Technology:Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 2Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 3Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 4Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 5Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 6Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Double Maddox...
Maddox Rod, short handle (12cm)...
... The Snellen chart remains to most ... range of different optotypes can be ... sheridan-gardner, landolt Cs, tumbling Es and ... column can be shown and a ...
Medicine Products: